Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

[HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study].

Alshakarchi J, Terént A.

Lakartidningen. 2012 Sep 19-26;109(38):1670-2. Swedish. No abstract available.

PMID:
23094397
2.

Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.

Guo Y, Lip GY, Apostolakis S.

Hosp Pract (1995). 2013 Feb;41(1):71-8. doi: 10.3810/hp.2013.02.1012. Review.

PMID:
23466969
3.

Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma.

Hohnloser SH.

J Am Coll Cardiol. 2011 Jan 11;57(2):181-3. doi: 10.1016/j.jacc.2010.09.026. Epub 2010 Nov 24. No abstract available.

4.

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.

5.

Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.

Lip GY.

Europace. 2011 Feb;13(2):145-8. doi: 10.1093/europace/euq427. Epub 2010 Dec 7. No abstract available.

PMID:
21138929
6.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
8.

Anticoagulation for atrial fibrillation patients with CHADS score of 1.

Lane DA, Lip GY.

J Cardiovasc Electrophysiol. 2010 May;21(5):508-10. doi: 10.1111/j.1540-8167.2009.01687.x. Epub 2010 Jan 15. No abstract available.

PMID:
20082649
9.

[Anticoagulation in atrial fibrillation].

Binggeli C, Brunckhorst CB.

Herz. 2008 Feb;33(1):13-9. doi: 10.1007/s00059-008-3090-8. Review. German.

PMID:
18273573
12.

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.

Lane DA, Lip GY.

Thromb Haemost. 2009 May;101(5):802-5. No abstract available. Erratum in: Thromb Haemost.2010 Sep;104(3):653.

PMID:
19404530
13.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P.

Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Swedish. No abstract available.

PMID:
19006862
14.

Bleeding risk on warfarin among elderly patients with atrial fibrillation.

Cowan A, Hylek EM.

J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037. No abstract available.

15.

Anticoagulation in the elderly.

Henderson MC, White RH.

Curr Opin Pulm Med. 2001 Sep;7(5):365-70. Review.

PMID:
11584191
16.

[Characterisation of thromboembolic risk in a mexican population with non-valvular atrial fibrillation and its effect on anticoagulation (MAYA Study)].

Vázquez-Acosta JA, Ramírez-Gutiérrez ÁE, Cerecedo-Rosendo MA, Olivera-Barrera FM, Tenorio-Sánchez SS, Nieto-Villarreal J, González-Borjas JM, Villanueva-Rodríguez E.

Gac Med Mex. 2016 Jul-Aug;152(4):473-8. Spanish.

17.

[Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].

[No authors listed]

MMW Fortschr Med. 2011 Sep 15;153(37):16. German. No abstract available.

PMID:
21950182
18.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

19.

Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.

Olesen JB, Lip GY, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Weeke P, Hansen ML, Gislason GH, Torp-Pedersen C.

J Thromb Haemost. 2011 Aug;9(8):1460-7. doi: 10.1111/j.1538-7836.2011.04378.x.

20.

The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?

Pamukcu B, Lane DA, Lip GY.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1703-10. doi: 10.1586/erc.10.153. Review.

PMID:
21108552

Supplemental Content

Support Center